{"id":1014405,"date":"2026-10-27T19:51:06","date_gmt":"2026-10-27T23:51:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/"},"modified":"2026-10-27T19:51:06","modified_gmt":"2026-10-27T23:51:06","slug":"urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/","title":{"rendered":"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026"},"content":{"rendered":"<h2>\nConference Call and Webcast Scheduled for Wednesday, November 4th, 2026, at 10:00 AM ET<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>PRINCETON, N.J., Oct.  27, 2026  (GLOBE NEWSWIRE) &#8212; UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report third quarter 2026 financial results on Wednesday, November 4<sup>th<\/sup>, 2026, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time.<\/p>\n<p>A live public webcast of the earnings conference call can be accessed on UroGen\u2019s Investor Relations <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HFLSf6DSl3fyiT1kWhXe8H7HUsp2FWDx9MXEdQ79wzEFr6bv-JzTKttYtUWB-F3DEqoN6-RIz0xaucJ6vq_RKQ==\" rel=\"nofollow\" target=\"_blank\">website<\/a>. Following the live webcast, a replay will be available on the site for approximately 30 days.<\/p>\n<p>\n        <strong>About UroGen Pharma Ltd.<\/strong>\n      <\/p>\n<p>UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed <em>RTGel\u00ae <\/em>reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the potential to improve the therapeutic profiles of existing drugs. UroGen\u2019s sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. Our first product to treat low-grade upper tract urothelial cancer and our second product for adult patients with recurrent LG-IR-NMIBC, are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IIP_vVaT398g8E6BazZ8LviSlgTSHbBhDHSXv74LOnY3IwArHTH_eNRHnRCTuohh9QnnFQSyiSaEbo_FwxM6pw==\" rel=\"nofollow\" target=\"_blank\">www.UroGen.com<\/a> to learn more or follow us on X, @UroGenPharma.<\/p>\n<p>INVESTOR CONTACT:<\/p>\n<p>Vincent Perrone<br \/>Senior Director, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f-ZoQqpdR__1uGb9lVCvFLXL5xzt1FdLaSqQu1arvJAa7KstTkBxrgaaGSmrfAd5vED9u7XRmuv7PmlStrMrFatu3auAd5VTZ2QKnjPZqDHUw87X5e6ti6RrTvSrOTNp\" rel=\"nofollow\" target=\"_blank\">vincent.perrone@urogen.com<\/a><br \/>609-460-3588 ext. 1093<\/p>\n<p>MEDIA CONTACT:<\/p>\n<p>Cindy Romano<br \/>Director, Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b90zjzCY-sI4eiAj3a9Gq1M_CnfNtGshV8NzneVXmmrlyagn2IkX0YyjtbeX64fPTaq1e129KV1bL2vYf6E7Xsbeo7Sui8D04F2VdUW8cSI=\" rel=\"nofollow\" target=\"_blank\">cindy.romano@urogen.com<\/a><br \/>609-460-3566 ext. 1083<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTNiYmIzMTgtODllNi00YTkyLTllNWEtNjdhMmEwMjE2NTNhLTEwNDA1OTAtMjAyNi0xMC0yNy1lbg==\/tiny\/UroGen-Pharma-Ltd-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Conference Call and Webcast Scheduled for Wednesday, November 4th, 2026, at 10:00 AM ET PRINCETON, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report third quarter 2026 financial results on Wednesday, November 4th, 2026, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time. A live public webcast of the earnings conference call can be accessed on UroGen\u2019s Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days. About UroGen &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1014405","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Conference Call and Webcast Scheduled for Wednesday, November 4th, 2026, at 10:00 AM ET PRINCETON, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report third quarter 2026 financial results on Wednesday, November 4th, 2026, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time. A live public webcast of the earnings conference call can be accessed on UroGen\u2019s Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days. About UroGen &hellip; Continue reading &quot;UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-27T23:51:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026\",\"datePublished\":\"2026-10-27T23:51:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/\"},\"wordCount\":280,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/\",\"name\":\"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk=\",\"datePublished\":\"2026-10-27T23:51:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/","og_locale":"en_US","og_type":"article","og_title":"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026 - Market Newsdesk","og_description":"Conference Call and Webcast Scheduled for Wednesday, November 4th, 2026, at 10:00 AM ET PRINCETON, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report third quarter 2026 financial results on Wednesday, November 4th, 2026, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time. A live public webcast of the earnings conference call can be accessed on UroGen\u2019s Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days. About UroGen &hellip; Continue reading \"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-27T23:51:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026","datePublished":"2026-10-27T23:51:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/"},"wordCount":280,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/","name":"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk=","datePublished":"2026-10-27T23:51:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDY0OSM3OTIwNDQ5IzIwMjkwMTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-report-third-quarter-2026-financial-results-on-wednesday-november-4th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1014405","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1014405"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1014405\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1014405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1014405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1014405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}